Rethinking recommendations for screening for depression in primary care

Brett D. Thombs; James C. Coyne; Pim Cuijpers; Peter De Jonge; Simon Gilbody; John P.A. Ioannidis; Blair T. Johnson; Scott B. Patten; Erick H. Turner; Roy C. Ziegelstein

doi:10.1503/cmaj.111035

Rethinking recommendations for screening for depression in primary care

Brett D. Thombs, James C. Coyne, Pim Cuijpers, Peter De Jonge, Simon Gilbody, John P.A. Ioannidis, Blair T. Johnson, Scott B. Patten, Erick H. Turner, Roy C. Ziegelstein

School of Medicine

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	413-418
Number of pages	6
Journal	CMAJ
Volume	184
Issue number	4
DOIs	https://doi.org/10.1503/cmaj.111035
State	Published - Mar 6 2012

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1503/cmaj.111035

Cite this

Rethinking recommendations for screening for depression in primary care. / Thombs, Brett D.; Coyne, James C.; Cuijpers, Pim; De Jonge, Peter; Gilbody, Simon; Ioannidis, John P.A.; Johnson, Blair T.; Patten, Scott B.; Turner, Erick H.; Ziegelstein, Roy C.

In: CMAJ, Vol. 184, No. 4, 06.03.2012, p. 413-418.

Research output: Contribution to journal › Review article › peer-review

@article{7deefa1a0c7e4303b4c1279a794a4e48,

title = "Rethinking recommendations for screening for depression in primary care",

author = "Thombs, {Brett D.} and Coyne, {James C.} and Pim Cuijpers and {De Jonge}, Peter and Simon Gilbody and Ioannidis, {John P.A.} and Johnson, {Blair T.} and Patten, {Scott B.} and Turner, {Erick H.} and Ziegelstein, {Roy C.}",

note = "Funding Information: Competing interests: Blair Johnson is a consultant for the American College of Sports Medicine. Scott Patten is a consultant for Cipher Pharmaceuticals and Servier Canada; he has provided expert testimony for Cipher Pharmaceuticals concerning safety provisions during a clinical trial for an acne medication associated with adverse psychiatric effects; he has received grant funding from Servier Canada to research the use of benziodiazepines and changes in weight associated with treatment with antidepressant medications; and he has received speaker fees from Lundbeck. No other competing interests were declared. Funding Information: Funding: Funds from a Meetings, Planning and Dissemination grant from the Canadian Institutes of Health Research (CIHR; grant no. MIN 92725 ) were used for a meeting of the author group, which led to the preparation of this article. Dr. Thombs is supported by a New Investigator Award from the CIHR and an {\'E}tablissement de Jeunes Chercheurs award from the Fonds de la Recherche en Sant{\'e} Qu{\'e}bec. Dr. Patten is a Senior Health Scholar with Alberta Innovates, Health Solutions. Dr. Ziegelstein is supported by the National Center for Complementary and Alternative Medicine (grant no. R24AT004641 ) and the Miller Family Scholar Program of the Johns Hopkins Center for Innovative Medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Complementary and Alternative Medicine or the National Institutes of Health. ",

year = "2012",

month = mar,

day = "6",

doi = "10.1503/cmaj.111035",

language = "English (US)",

volume = "184",

pages = "413--418",

journal = "Canadian Medical Association journal",

issn = "0008-4409",

publisher = "Canadian Medical Association",

number = "4",

}

TY - JOUR

T1 - Rethinking recommendations for screening for depression in primary care

AU - Thombs, Brett D.

AU - Coyne, James C.

AU - Cuijpers, Pim

AU - De Jonge, Peter

AU - Gilbody, Simon

AU - Ioannidis, John P.A.

AU - Johnson, Blair T.

AU - Patten, Scott B.

AU - Turner, Erick H.

AU - Ziegelstein, Roy C.

N1 - Funding Information: Competing interests: Blair Johnson is a consultant for the American College of Sports Medicine. Scott Patten is a consultant for Cipher Pharmaceuticals and Servier Canada; he has provided expert testimony for Cipher Pharmaceuticals concerning safety provisions during a clinical trial for an acne medication associated with adverse psychiatric effects; he has received grant funding from Servier Canada to research the use of benziodiazepines and changes in weight associated with treatment with antidepressant medications; and he has received speaker fees from Lundbeck. No other competing interests were declared. Funding Information: Funding: Funds from a Meetings, Planning and Dissemination grant from the Canadian Institutes of Health Research (CIHR; grant no. MIN 92725 ) were used for a meeting of the author group, which led to the preparation of this article. Dr. Thombs is supported by a New Investigator Award from the CIHR and an Établissement de Jeunes Chercheurs award from the Fonds de la Recherche en Santé Québec. Dr. Patten is a Senior Health Scholar with Alberta Innovates, Health Solutions. Dr. Ziegelstein is supported by the National Center for Complementary and Alternative Medicine (grant no. R24AT004641 ) and the Miller Family Scholar Program of the Johns Hopkins Center for Innovative Medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Complementary and Alternative Medicine or the National Institutes of Health.

PY - 2012/3/6

Y1 - 2012/3/6

UR - http://www.scopus.com/inward/record.url?scp=84857824487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857824487&partnerID=8YFLogxK

U2 - 10.1503/cmaj.111035

DO - 10.1503/cmaj.111035

M3 - Review article

C2 - 21930744

AN - SCOPUS:84857824487

VL - 184

SP - 413

EP - 418

JO - Canadian Medical Association journal

JF - Canadian Medical Association journal

SN - 0008-4409

IS - 4

ER -

Rethinking recommendations for screening for depression in primary care

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this